Comparing 2 hypotheses side-by-side
## Mechanistic Overview Glial Neuroinflammatory Amplification by TDP-43 Pathology starts from the claim that modulating TARDBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Glial Neuroinflammatory Amplification by TDP-43 Pathology starts from the claim that modulating TARDBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "##
## Mechanistic Overview Cross-Seeding Prevention Strategy starts from the claim that modulating TARDBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The cross-seeding prevention strategy targets the pathological interaction between TAR DNA-binding protein 43 (TDP-43), encoded by TARDBP, and classical neurodegenerative disease proteins such as amyloid-beta (Aβ), tau, and alpha-synucle
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | Glial Neuroinflammatory Amplif | Cross-Seeding Prevention Strat |
|---|---|---|
| Mechanistic | 0.720 | 0.720 |
| Evidence | 0.700 | 0.680 |
| Novelty | 0.750 | 0.550 |
| Feasibility | 0.680 | 0.640 |
| Impact | 0.780 | 0.710 |
| Druggability | 0.800 | 0.580 |
| Safety | 0.580 | 0.620 |
| Competition | 0.520 | 0.480 |
| Data | 0.680 | 0.750 |
| Reproducible | 0.620 | 0.590 |
| KG Connect | 0.500 | 0.788 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.73
# Mechanistic Hypotheses: TDP-43 Contribution to Cognitive Impairment Severity in AD ## Hypothesis 1: Synaptic RNA Metabolism Dysregulation **Title:** TDP-43-mediated disruption of synaptic mRNA tra...
# Critical Evaluation of TDP-43 Cognitive Impairment Mechanisms in AD ## Hypothesis 1: Synaptic RNA Metabolism Dysregulation **Weak Links:** - **Assumes nuclear loss-of-function dominance**: In AD, ...
# Feasibility Assessment: TDP-43 Mechanisms in AD Cognitive Impairment ## Pre-Assessment Filter | Hypothesis | Theorist Confidence | Skeptic Revised | Survives? | Rationale | |------------|---------...
{"ranked_hypotheses":[{"title":"Glial Neuroinflammatory Amplification by TDP-43 Pathology","description":"TDP-43 pathology in astrocytes and microglia drives non-cell-autonomous neuroinflammation thro...
4 rounds · quality: 0.92
# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...
# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...
# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...
# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["Cellular Stress Triggers"]
B["TARDBP Gene Expression"]
C["TDP-43 Protein Synthesis"]
D["Nuclear TDP-43 Function"]
E["Cytoplasmic TDP-43 Mislocalization"]
F["TDP-43 Conformational Change"]
G["Beta-Sheet Formation"]
H["Cross-Seeding with Amyloid-beta"]
I["Cross-Seeding with Tau Protein"]
J["Cross-Seeding with Alpha-Synuclein"]
K["Heterotypic Protein Aggregates"]
L["Neuronal Dysfunction"]
M["Synaptic Loss"]
N["Neurodegeneration"]
O["RNA Splicing Modulators"]
P["Protein Disaggregation Therapy"]
A -->|"induces"| B
B -->|"transcribes"| C
C -->|"maintains"| D
A -->|"disrupts"| E
C -->|"mislocalizes"| E
E -->|"triggers"| F
F -->|"promotes"| G
G -->|"initiates"| H
G -->|"initiates"| I
G -->|"initiates"| J
H -->|"forms"| K
I -->|"forms"| K
J -->|"forms"| K
K -->|"causes"| L
L -->|"leads to"| M
M -->|"results in"| N
O -->|"prevents"| E
P -->|"dissolves"| K
classDef mechanism fill:#4fc3f7
classDef pathology fill:#ef5350
classDef therapy fill:#81c784
classDef outcome fill:#ffd54f
classDef genetics fill:#ce93d8
class A,F,G mechanism
class E,H,I,J,K,L pathology
class O,P therapy
class M,N outcome
class B,C,D genetics